Spartalizumab
Spartalizumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Spartalizumab is under investigation in clinical trial NCT02605967 (Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma).
| Trade Name | Spartalizumab |
| Generic | Spartalizumab |
| Spartalizumab Other Names | Spartalizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Spartalizumab
